ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Risk for Stillbirth Elevated for Deliveries With COVID-19 Drugs
November 23, 2021The risk for stillbirth is elevated in deliveries with versus without COVID-19, according to research published in the Nov. 19 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Pharma Sources Insight July 2025
